...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Biogen/Eisai Scrap Aducanumab
7
Mar 21, 2019 08:32AM
2
Mar 21, 2019 03:07PM
3
Mar 21, 2019 03:37PM

Study 201-"randomized Phase II clinical study in 856 patients with mild cognitive impairment (MCI) due to Alzheimer's disease or mild Alzheimer's dementia (collectively known as early Alzheimer’s disease) with confirmed amyloid pathology in the brain."

Seems to be for early-onset of the AD. How would this compare to the 250 patients in the BOM trial?

 

Koo

5
Mar 23, 2019 03:39PM
2
Mar 24, 2019 01:45AM
3
Mar 24, 2019 01:22PM
2
Mar 24, 2019 03:35PM
2
Mar 25, 2019 10:18AM
1
Mar 25, 2019 11:45AM
2
Mar 25, 2019 12:48PM
Share
New Message
Please login to post a reply